ACT-064992D (Yubansi) approval and launch preparations

A discrete product commercialization theme involving launch preparations and joint information activities following Janssen Pharmaceutical’s receipt of marketing approval for ACT-064992D (Yubansi).

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2025-H1 →Last written FY2025-H1

Directionhelps1 helps · 0 hurts · 0 flat

Loading